2023
DOI: 10.1165/rcmb.2023-0171ed
|View full text |Cite
|
Sign up to set email alerts
|

Aging Delays Lung Repair: Insights from Omics Analysis in Mice with Pulmonary Fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…However, based on our normalized gene expressions of collagen, lysyl oxidase, and proteases, older mice did not show significant dysregulation levels than younger mice in most fibrotic markers. It has been reported that the bleomycin-induced fibrosis model serves better in the old mice, in which the chronological aging could delay fibroblast-dominated repair capacity, hence inducing persistent scarring and ECM deposition, whereas young mice showed recovery in lung scarring [ 55 , 56 ]. Bleomycin treatment for 14 days might not be enough for mimicking the fibrogenesis progression in humans since it is a chronic lung disease.…”
Section: Discussionmentioning
confidence: 99%
“…However, based on our normalized gene expressions of collagen, lysyl oxidase, and proteases, older mice did not show significant dysregulation levels than younger mice in most fibrotic markers. It has been reported that the bleomycin-induced fibrosis model serves better in the old mice, in which the chronological aging could delay fibroblast-dominated repair capacity, hence inducing persistent scarring and ECM deposition, whereas young mice showed recovery in lung scarring [ 55 , 56 ]. Bleomycin treatment for 14 days might not be enough for mimicking the fibrogenesis progression in humans since it is a chronic lung disease.…”
Section: Discussionmentioning
confidence: 99%
“…However, based on our normalized gene expressions of collagen, lysyl oxidase, and proteases, older mice did not show significant dysregulation levels than younger mice in most fibrotic markers. It has been reported that the bleomycin-induced fibrosis model serves better in the old mice, in which the chronological aging could delay fibroblast-dominated repair capacity, hence inducing persistent scarring and ECM deposition, whereas young mice showed recovery in lung scarring ( 50 , 51 ). Bleomycin treatment for 14 days might not be enough for mimicking the fibrogenesis progression in humans since it is a chronic lung disease.…”
Section: Discussionmentioning
confidence: 99%